Showing results (1-10 of 3,155) with videos related to

Sort By:
Pageof 316
Translational Oncology|November 19, 2021
Elacestrant in metastatic breast cancer: Is the "standard of care" meeting standard requirements?Timothée Olivier, Vinay Prasad
Translational Oncology|November 20, 2021
Factors associated with immunotherapy respond and survival in advanced non-small cell lung cancer patientsYahua Wu, Haishan Wu, Mingqiang Lin, et al.
Translational Oncology|November 20, 2021
A method of separating extracellular vesicles from blood shows potential clinical translation, and reveals extracellular vesicle cargo gremlin-1 as a diagnostic biomarkerNiamh McNamee, Róisín Daly, John Crown, et al.
Translational Oncology|March 17, 2021
MicroRNA-181a suppresses norethisterone-promoted tumorigenesis of breast epithelial MCF10A cells through the PGRMC1/EGFR-PI3K/Akt/mTOR signaling pathwayGuiju Cai, Yuejiao Wang, Tahiri Houda, et al.
Translational Oncology|November 25, 2021
p.G12C KRAS mutation prevalence in non-small cell lung cancer: Contribution from interregional variability and population substructures among HispanicsAlejandro Ruiz-Patiño, July Rodríguez, Andrés F Cardona, et al.
Translational Oncology|November 18, 2021
Canine insulinoma as a model for human malignant insulinoma research: Novel perspectives for translational clinical studiesYlenia Capodanno, Barbara Altieri, Richard Elders, et al.
Translational Oncology|March 12, 2019
The Third-Generation EGFR Inhibitor, Osimertinib, Promotes c-FLIP Degradation, Enhancing Apoptosis Including TRAIL-Induced Apoptosis in NSCLC Cells with Activating EGFR MutationsPuyu Shi, Shuo Zhang, Lei Zhu, et al.
Translational Oncology|November 16, 2018
High Keratin 8/18 Ratio Predicts Aggressive Hepatocellular Cancer PhenotypeNicole Golob-Schwarzl, Kira Bettermann, Anita Kuldeep Mehta, et al.
Translational Oncology|November 18, 2018
Establishment of a Novel PDX Mouse Model and Evaluation of the Tumor Suppression Efficacy of Bortezomib Against LiposarcomaEun Byeol Jo, Doopyo Hong, Young Sang Lee, et al.
Translational Oncology|November 10, 2018
Enhancing the Radiation Response in KRAS Mutant Colorectal Cancers Using the c-Met Inhibitor CrizotinibKyle C Cuneo, Ranjit K Mehta, Himabindu Kurapati, et al.
Pageof 316